A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Participants (MOMENTUM)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ruben Mesa
UT Health San Antonio Cancer Center, San Antonio, TX, USA
Principal InvestigatorKOL profile → - Srdan Verstovsek, M.D., Ph.D.
Department of Leukemia, The University of Texas MD Anderson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
167 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Canberra Region Cancer Centre
Garran, Australian Capital Territory, Australia
- Calvary Mater Newcastle Hospital
Waratah, New South Wales, Australia
- Flinders Medical Centre
Bedford Park, South Australia, Australia
- the Alfred Hospital
Melbourne, Victoria, Australia
- Perth Radiological Clinic - Magnetic Resonance Centre
Perth, Western Australia, Australia
- Medizinische Universität Wien
Vienna, State of Vienna, Austria
- Medizinische Universität Innsbruck
Innsbruck, Tyrol, Austria
- Ordensklinikum Linz Elisabethinen
Linz, Upper Austria, Austria
- Oberösterreichische Gesundheitsholding Gmbh
Steyr, Austria
- Hôpital Erasme
Brussels, Brussels Capital, Belgium
- Grand Hôpital de Charleroi - Notre Dame
Charleroi, Hainaut, Belgium
- Algemeen Ziekenhuis Sint-Jan Brugge-Oostende - Campus Sint-Jan
Bruges, West-Vlaanderen, Belgium
- Ziekenhuis Netwerk Antwerpen Stuivenberg
Antwerp, Belgium
- Centre Hospitalier Universitaire de Liège
Liège, Belgium
- University Multiprofile Hospital for Active Treatment Dr. Georgi Stranski Ead
Pleven, Bulgaria
- National Specialized Hospital for Active Treatment of Haematologic Diseases
Sofia, Bulgaria
- University Hospital St. Ivan Rilski
Sofia, Bulgaria
- University Multiprofile Hospital for Active Treatment Aleksandrovska
Sofia, Bulgaria
- Saint Paul'S Hospital
Vancouver, British Columbia, Canada
- Queen Elizabeth Ii Health Sciences Centre - Halifax Infirmary
Halifax, Nova Scotia, Canada
- Mcmaster University Medical Center
Hamilton, Ontario, Canada
- Princess Margaret Cancer Centre
Toronto, Ontario, Canada
- Research Institute of the Mcgill University Health Centre
Montreal, Quebec, Canada
- Hôpital de L'Enfant-Jésus
Québec, Canada
- Fakultni Nemocnice Brno
Brno, Jihormoravsky Kraj, Czechia
- Herlev Hospital
Herlev, Capital Region, Denmark
- Aalborg Universitetshospital - Syd
Aalborg, North Denmark, Denmark
- Sjællands Universitetshospital - Roskilde
Roskilde, Region Sjælland, Denmark
- Odense Universitetshospital
Odense, Region Syddanmark, Denmark
- Hôpital Haut-Lévêque
Pessac, Aquitaine, France
- Hospital Center University of Caen Normandie
Caen, Basse-Normandie, France
- Hôpital Claude Huriez
Lille, Hauts-de-France, France
- Centre Hospitalier Universitaire Limoges
Limoges, Limousin, France
- Centre Hospitalier de Lens
Lens, Nord Pas-Des-Calais, France
- Centre Hospitalier Le Mans
Le Mans, Pays de la Loire Region, France
- Centre Hospitalier Universitaire Amiens-Picardie - Site Sud
Amiens, Picardie, France
- Hôpital L'Archet
Nice, Provence-Alpes-Côte d'Azur Region, France
- Centre Hospitalier Lyon-Sud
Pierre-Bénite, Rhone-Alps, France
- Hôpital Saint-Antoine
Paris, Île-de-France Region, France
- Hôpital Saint-Louis
Paris, Île-de-France Region, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Feb 2020
- Primary completion
- 3 Dec 2021
- Completion
- 29 Dec 2022
- Last update posted
- 1 Nov 2023
- Registered enrollment
- 195
- Registry id
- NCT04173494
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.